Willingness to vaccinate against COVID-19 in Australia

Dodd, Rachael H; Cvejic, Erin; Bonner, Carissa; Pickles, Kristen; McCaffery, Kirsten; Ayre, Julie; Batcup, Carys; Copp, Tessa; Cornell, Samuel; Dakin, Thomas; Isautier, Jennifer; Nickel, Brooke

doi:10.1016/s1473-3099(20)30559-4

Cited by 276 publications

(328 citation statements)

References 4 publications

Supporting

Mentioning

276

Contrasting

Order By: Relevance

“…The difference in acceptance rate documented in this study may be due to a single or combination of factor(s) including: (1) the variation in the wording of the question; (2) high level of confidence and trust in the Australian government [6] or (3) due to concerns about increasing local transmission which were high at the time. However, our results align with other Australian studies, which have reported willingness levels between 76% to 86% [13,14]. Both studies collected the data in April 2020.…”

Section: Discussionsupporting

confidence: 91%

Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine

Seale

Heywood

Leask

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: There is an indication that vaccine(s) for COVID-19 could be available by early 2021. As immunisation program launches have previously demonstrated, it is essential that careful planning occurs now to ensure the readiness of the public for a COVID-19 vaccine. As part of that process, this study aimed to understand the public perceptions regarding a future COVID-19 vaccine in Australia. Methods: A national cross-sectional online survey of 1420 Australian adults (18 years and older) was undertaken between 18 and 24 March 2020. The statistical analysis of the data included univariate and multivariate logistic regression analysis. Results: Participants generally held positive views towards vaccination. Eighty percent (n=1143) agreed with the statement that getting myself vaccinated for COVID-19 would be a good way to protect myself against infection. Females (614, 83%) were more likely to agree with the statement than males (529, 78%) (aOR=1.4 (95% CI: 1.1-1.8); P=0.029), while 90.9% aged 70 and above agreed compared to 76.6% aged 18-29 year old (aOR=2.3 (95% CI:1.2-4.1); 0.008). Agreement was also higher for those with a self-reported chronic disease (aOR=1.4 (95% CI: 1.1-2.0); P=0.043) and among those who held private health insurance (aOR=1.7 (95% CI: 1.3-2.3); P<0.001). Beyond individual perceptions, 78% stated that their decision to vaccinate would be supported by family and friends Conclusion: This study presents an early indication of public perceptions towards a future COVID-19 vaccine and represents a starting point for mapping vaccine perceptions. To support an effective launch of these new vaccines, governments need to use this time to understand the communities concerns and to identify the strategies that will support engagement.

show abstract

Section: Discussionsupporting

confidence: 91%

Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine

Seale

Heywood

Leask

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Consistent with the present study, other studies appearing after our study had been completed have found that vaccination hesitancy is associated with negative attitudes toward a SARSCoV2 vaccine, including concerns about safety and efficacy (Fisher et al, 2020;Neumann-Böhme et al, 2020;Palamenghi et al, 2020), and doubts about the necessity for vaccination (Dodd et al, 2020). Findings from the present study, along with results from previous studies, have important implications for public policy.…”

Section: Discussionsupporting

confidence: 90%

“…The degree of vaccination hesitancy found in the present study is broadly consistent with other studies that were published after our study had been completed. Studies conducted during March-April 2020, which was somewhat earlier than the present study (May, 2020), reported findings broadly similar to ours in terms of percentages of people who stated that they would not get vaccinated against SARS-CoV2: Italy (14%) (Barello et al, 2020), France (26%) (COCONEL Group, 2020), and Australia (14%) (Dodd et al, 2020). In a European survey in June, 2020, 24% of respondents stated that they were either unwilling or unsure about getting vaccinated (Neumann-Böhme et al, 2020).…”

Section: Discussionsupporting

confidence: 84%

A Proactive Approach for Managing COVID-19: The Importance of Understanding the Motivational Roots of Vaccination Hesitancy for SARS-CoV2

et al. 2020

View full text Add to dashboard Cite

Importance: Vaccination hesitancy-the reluctance or refusal to be vaccinated-is a leading global health threat (World Health Organization, 2019). It is imperative to identify the prevalence of vaccination hesitancy for SARS-CoV2 in order to understand the scope of the problem and to identify its motivational roots in order to proactively prepare to address the problem when a vaccine eventually becomes available. Objective: To identify (1) the prevalence of vaccination hesitancy for a SARS-CoV2 vaccine, (2) the motivational roots of this hesitancy, and (3) the most promising incentives for improving the likelihood of vaccination uptake when a vaccine does become available. Design, Setting, and Participants: A cross-sectional sample of 3,674 American and Canadian adults assessed during the COVID-19 pandemic in May 2020. Main Outcomes: Measures of vaccination intention (i.e., "If a vaccine for COVID-19 was available, would you get vaccinated?"), attitudes toward vaccines in general and specific to SARS-CoV2 using the Vaccination Attitudes Examination Scale, and incentives for getting vaccinated for those who reported they would not get vaccinated. Results: Many American (25%) and Canadian (20%) respondents said that they would not get vaccinated against SARS-CoV2 if a vaccine was available. Nonadherence rates of this magnitude would make it difficult or impossible to achieve herd immunity. Vaccine rejection was most strongly correlated with mistrust of vaccine benefit, and also correlated with worry about unforeseen future effects, concerns about commercial profiteering from pharmaceutical companies, and preferences for natural immunity. When asked about incentives for getting vaccinated, respondents were most likely to report that evidence for rigorous testing and safety of the vaccine were of greatest importance.

show abstract

“…However, the success of any vaccination programme depends on high vaccine acceptance and uptake. Previously, Rachael Dodd and colleagues 1 reported that 4·9% of adults in Australia would refuse a vaccine, which is low compared with estimates in the USA (20%) 2 and France (27%). 3 The Australian data were collected in April, 2020, 4 weeks after lockdown measures commenced, which was at a time when community transmission was perceived to be high.…”

mentioning

confidence: 95%

Intention to vaccinate against COVID-19 in Australia

Rhodes

Hoq

Measey

et al. 2021

The Lancet Infectious Diseases

262

241

View full text Add to dashboard Cite

different population groups to ensure public health campaigns remain responsive to community vaccine sentiments. Given the potential impact of vaccine hesitancy on the required population herd immunity threshold, we need to understand the attitudinal and behavioural drivers in order to inform community-led communication strategies to build trust and optimise COVID-19 vaccine uptake.We declare no competing interests.

show abstract

Willingness to vaccinate against COVID-19 in Australia

Cited by 276 publications

References 4 publications

Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine

Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine

A Proactive Approach for Managing COVID-19: The Importance of Understanding the Motivational Roots of Vaccination Hesitancy for SARS-CoV2

Intention to vaccinate against COVID-19 in Australia

Contact Info

Product

Resources

About